192 related articles for article (PubMed ID: 32880812)
1. Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.
Arai Y; Ogawa M; Yamane F; Sumiyoshi N; Arimoto R; Ando Y; Endo D; Nakada T; Sugawara I; Yokoyama H; Shimoyama K; Inomata H; Kawahara Y; Kato M; Arihiro S; Hokari A; Saruta M
Clin J Gastroenterol; 2020 Dec; 13(6):1200-1204. PubMed ID: 32880812
[TBL] [Abstract][Full Text] [Related]
2. Mesalazine allergy in a boy with ulcerative colitis: clinical usefulness of mucosal biopsy criteria.
Wada S; Kumagai H; Yokoyama K; Ito T; Miyauchi A; Sakamoto S; Imagawa T; Tulyeu J; Tanaka M; Yamagata T
Clin J Gastroenterol; 2016 Oct; 9(5):302-5. PubMed ID: 27503129
[TBL] [Abstract][Full Text] [Related]
3. Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.
Buurman DJ; De Monchy JG; Schellekens RC; van der Waaij LA; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2015 Apr; 50(4):399-405. PubMed ID: 25633468
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].
Machida H; Shinohara T; Hatakeyama N; Inayama M; Hosokawa E; Ogushi F
Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):538-42. PubMed ID: 21842693
[TBL] [Abstract][Full Text] [Related]
5. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
6. Mesalazine-induced multi-organ hypersensitivity.
Sposato B; Allegri MP; Riccardi MP; Chigiotti S; Nencioni C; Ricciardi B; Carli T; Cresti A; Perari MG; Migliorini MG; Toti M
Clin Drug Investig; 2010; 30(6):413-7. PubMed ID: 20441247
[TBL] [Abstract][Full Text] [Related]
7. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R; Matsumoto S; Miyatani H; Mashima H
Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
[TBL] [Abstract][Full Text] [Related]
8. [THREE CASES OF DRUG-INDUCED PNEUMONIA CAUSED BY MESALAZINE].
Akiyama N; Yokomura K; Nozue T; Abe T; Matsui T; Suda T
Arerugi; 2015 Dec; 64(10):1334-40. PubMed ID: 26727138
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
Raedler A; Behrens C; Bias P
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1353-63. PubMed ID: 15606398
[TBL] [Abstract][Full Text] [Related]
10. Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Active Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study.
Sun J; Yuan Y
Adv Ther; 2016 Mar; 33(3):400-9. PubMed ID: 26898569
[TBL] [Abstract][Full Text] [Related]
11. Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.
Ferrusquía J; Pérez-Martínez I; Gómez de la Torre R; Fernández-Almira ML; de Francisco R; Rodrigo L; Riestra S
World J Gastroenterol; 2015 Apr; 21(13):4069-77. PubMed ID: 25852295
[TBL] [Abstract][Full Text] [Related]
12. Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
Frattini F; Crestani S; Vescovi PP; Franchini M
Hematology; 2013 May; 18(3):181-2. PubMed ID: 23321335
[TBL] [Abstract][Full Text] [Related]
13. [A case of lung injury induced by long-term administration of mesalazine].
Shindoh Y; Horaguchi R; Hayashi K; Suda Y; Iijima H; Shindoh C
Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):861-6. PubMed ID: 22171492
[TBL] [Abstract][Full Text] [Related]
14. Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
Safdi AV; Cohen RD
Aliment Pharmacol Ther; 2007 Nov; 26(9):1179-86. PubMed ID: 17944732
[TBL] [Abstract][Full Text] [Related]
15. [Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].
Inatsuchi S; Nakajima T; Yoshio Y; Entani A; Okada K
Nihon Shokakibyo Gakkai Zasshi; 2004 Sep; 101(9):989-92. PubMed ID: 15478662
[No Abstract] [Full Text] [Related]
16. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Hanauer SB
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():37-40. PubMed ID: 16961743
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study.
Pokrotnieks J; Marlicz K; Paradowski L; Margus B; Zaborowski P; Greinwald R
Aliment Pharmacol Ther; 2000 Sep; 14(9):1191-8. PubMed ID: 10971236
[TBL] [Abstract][Full Text] [Related]
18. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
Clemett D; Markham A
Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
[TBL] [Abstract][Full Text] [Related]
19. Mesalazine-induced eosinophilic pneumonia.
Tanigawa K; Sugiyama K; Matsuyama H; Nakao H; Kohno K; Komuro Y; Iwanaga Y; Eguchi K; Kitaichi M; Takagi H
Respiration; 1999; 66(1):69-72. PubMed ID: 9973695
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hypersensitivity syndrome with lupus manifestations due to mesalazine in a patient with ulcerative colitis.
Zgheib O; Trombert V; Jandus P; Serratrice C
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35217557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
